Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-25 @ 2:25 AM
Ignite Modification Date:
2025-12-25 @ 2:25 AM
NCT ID:
NCT01009034
Eligibility Criteria:
Inclusion Criteria:
* HIV infected male
* 18 years old or older
* on maraviroc twice daily as part of their antiretroviral regimen for at least 3 months prior to screening
* viral load \< 50 copies/mL at least one month prior to enrolling
* able to read, understand and sign a written informed consent prior to initiation of the study
* medically stable at the time of the study, with no evidence of acute illness
Exclusion Criteria:
* having difficulty adhering to current antiretroviral therapy
* patient is expected to have difficulties adhering with study protocol
* patients with malignancy, or acute renal or liver disease
* patient with active AIDS-defining illness
* patient with any medical, psychiatric or other circumstance that may impede the provision of informed consent
* patient with any of the following abnormalities at the time of screening:
* hemoglobin \< 85 g/L
* absolute neutrophil count \< 1000 cells/uL
* platelet count \< 50,000 cells/uL
* AST, ALT or total bilirubin \> 3 times the upper limit of normal
* serum creatinine \> 1.5 times upper limit of normal
* patient receiving concomitant therapy with rifampin or St. John's wort
Healthy Volunteers:
True
Sex:
MALE
Minimum Age:
18 Years
Study:
NCT01009034
Study Brief:
Protocol Section:
NCT01009034